For more than 30 years, Dr. Guy Rouleau and his team have focused on identifying the genes causing several neurological and psychiatric diseases, including autism, amyotrophic lateral sclerosis, hereditary neuropathies, epilepsy and schizophrenia, as well as providing a better understanding of the molecular mechanisms that lead to these disease symptoms. Among Dr. Rouleau’s main achievements are his contribution to the identification of dozens of disease-causing genes and his discovery of new mutational mechanisms.
Dr. Rouleau has published over 900 articles in peer-reviewed journals and has been quoted more than 85 000 times (Google Scholar). He has supervised more than a hundred students at the Masters, PhD and Post-doctoral levels in addition to receiving numerous awards for his contribution to science and society.
Dr. Rouleau has received numerous awards, including the Michael Smith Award from the Canadian Institutes of Health Research, the Margolese National Brain Disorders Prize from the University of British Columbia, the Prix du Québec – Wilder Penfield from the Government of Québec, the Prix d’excellence of the Collège des médecins du Québec, and the Canada Gairdner Wightman Award from the Gairdner Foundation. He is an Officer of the National Order of Québec, an officer of the Order of Canada and a fellow of the Royal Society of Canada.
As co-founder of the Tanenbaum Open Science Institute, Dr. Rouleau is pioneering a new way of doing research by transforming The Neuro into the first academic institution to adopt Open Science principles in order to accelerate discovery and benefit patients and society.